These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36658044)

  • 21. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
    Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
    PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study.
    Erdem R; De Coster I; Withanage K; Mercer LD; Marchant A; Taton M; Cools N; Lion E; Cassels F; Higgins D; Ivinson K; Locke E; Mahmood K; Wright PF; Gast C; White JA; Ackerman ME; Konopka-Anstadt JL; Mainou BA; Van Damme P
    Vaccine; 2023 Mar; 41(10):1657-1667. PubMed ID: 36746739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial.
    Crothers JW; Ross Colgate E; Cowan KJ; Dickson DM; Walsh M; Carmolli M; Wright PF; Norton EB; Kirkpatrick BD
    Vaccine; 2022 Apr; 40(19):2705-2713. PubMed ID: 35367069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli.
    Maciel M; Bauer D; Baudier RL; Bitoun J; Clements JD; Poole ST; Smith MA; Kaminski RW; Savarino SJ; Norton EB
    Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.
    Qadri F; Akhtar M; Bhuiyan TR; Chowdhury MI; Ahmed T; Rafique TA; Khan A; Rahman SIA; Khanam F; Lundgren A; Wiklund G; Kaim J; Löfstrand M; Carlin N; Bourgeois AL; Maier N; Fix A; Wierzba T; Walker RI; Svennerholm AM
    Lancet Infect Dis; 2020 Feb; 20(2):208-219. PubMed ID: 31757774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with Salmonella Enteritidis secreting mucosal adjuvant labile toxin confers protection against wild type challenge via augmentation of CD3
    Lalsiamthara J; Lee JH
    Vaccine; 2017 Feb; 35(5):767-773. PubMed ID: 28063704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
    Harro C; Louis Bourgeois A; Sack D; Walker R; DeNearing B; Brubaker J; Maier N; Fix A; Dally L; Chakraborty S; Clements JD; Saunders I; Darsley MJ
    Vaccine; 2019 Mar; 37(14):1978-1986. PubMed ID: 30797634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A live attenuated Salmonella Enteritidis secreting detoxified heat labile toxin enhances mucosal immunity and confers protection against wild-type challenge in chickens.
    Lalsiamthara J; Kamble NM; Lee JH
    Vet Res; 2016 Jun; 47(1):60. PubMed ID: 27262338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection.
    Forsyth VS; Himpsl SD; Smith SN; Sarkissian CA; Mike LA; Stocki JA; Sintsova A; Alteri CJ; Mobley HLT
    mBio; 2020 Apr; 11(2):. PubMed ID: 32345645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.
    Luo Q; Vickers TJ; Fleckenstein JM
    Clin Vaccine Immunol; 2016 Jul; 23(7):628-37. PubMed ID: 27226279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.
    El-Kamary SS; Cohen MB; Bourgeois AL; Van De Verg L; Bauers N; Reymann M; Pasetti MF; Chen WH
    Clin Vaccine Immunol; 2013 Nov; 20(11):1764-70. PubMed ID: 24049109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral immunization of BALB/c mice with recombinant Helicobacter pylori antigens and double mutant heat-labile toxin (dmLT) induces prophylactic protective immunity against H. pylori infection.
    Zhong Y; Chen J; Liu Y; Zhang Y; Tang C; Wang X; Wang P; Chen W; Wei B; Liu M
    Microb Pathog; 2020 Aug; 145():104229. PubMed ID: 32353579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LTA1 and dmLT enterotoxin-based proteins activate antigen-presenting cells independent of PKA and despite distinct cell entry mechanisms.
    Valli E; Baudier RL; Harriett AJ; Norton EB
    PLoS One; 2020; 15(1):e0227047. PubMed ID: 31929548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
    Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
    Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive antibodies derived from intramuscularly immunized toxoid fusion 3xSTa
    Nandre RM; Duan Q; Wang Y; Zhang W
    Vaccine; 2017 Jan; 35(4):552-556. PubMed ID: 28017433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enterotoxigenic Escherichia coli heat-stable toxin and heat-labile toxin toxoid fusion 3xSTaN12S-dmLT induces neutralizing anti-STa antibodies in subcutaneously immunized mice.
    Nandre R; Ruan X; Duan Q; Zhang W
    FEMS Microbiol Lett; 2016 Nov; 363(21):. PubMed ID: 27810884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4
    Frederick DR; Goggins JA; Sabbagh LM; Freytag LC; Clements JD; McLachlan JB
    Mucosal Immunol; 2018 Mar; 11(2):549-561. PubMed ID: 28792004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the adjuvant effect of Salmonella-based Escherichia coli heat-labile toxin B subunits on the efficacy of a live Salmonella-delivered avian pathogenic Escherichia coli vaccine.
    Chaudhari AA; Lee JH
    Avian Pathol; 2013 Aug; 42(4):365-72. PubMed ID: 23815619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.
    Hagiwar Y; Tsuji T; Iwasaki T; Kadowaki S; Asanuma H; Chen Z; Komase K; Suzuki Y; Aizawa C; Kurata T; Tamura S
    Vaccine; 2001 Feb; 19(15-16):2071-9. PubMed ID: 11228379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling.
    Larena M; Holmgren J; Lebens M; Terrinoni M; Lundgren A
    J Immunol; 2015 Apr; 194(8):3829-39. PubMed ID: 25786687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.